Linezolid as a potential alternative to glycopeptide in treating Enterococcus faecium suspected cyst infection in a hemodialysis patient with autosomal-dominant polycystic kidney disease: A case report
Open Access
- 1 January 2026
- journal article
- case report
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 14
Abstract
Autosomal-dominant polycystic kidney disease is a clinically significant disorder associated with progressive renal impairment. In these patients, cyst infection is an important but variably occurring complication, and optimal antibiotic selection remains challenging owing to the limited available evidence and restricted antibiotic penetration into cysts. An 81-year-old Japanese man with autosomal-dominant polycystic kidney disease undergoing maintenance hemodialysis presented with fever and a suspected cyst infection. Blood cultures showed the fluoroquinolone-resistant Enterococcus faecium . Vancomycin was contraindicated due to allergy, and teicoplanin was ineffective. Oral linezolid was initiated, resulting in clinical improvement. However, treatment was discontinued after 15 days of therapy (on hospital day 27) because of grade 1 thrombocytopenia. This case contributes to the limited clinical evidence in this field and highlights the potential role of linezolid in the management of Enterococcus faecium suspected cyst infections in autosomal-dominant polycystic kidney disease when glycopeptides are ineffective or contraindicated.Keywords
This publication has 22 references indexed in Scilit:
- Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faeciumDiagnostic Microbiology and Infectious Disease, 2018
- Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic reviewNephrology Dialysis Transplantation, 2016
- Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2015
- European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolidClinical Microbiology and Infection, 2014
- Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Infected Hepatic and Renal Cysts: Differential Impact on Outcome in Autosomal Dominant Polycystic Kidney DiseaseNephron Clinical Practice, 2009
- Renal function as a predictor of linezolid-induced thrombocytopeniaInternational Journal of Antimicrobial Agents, 2009
- Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failureJournal of Infection and Chemotherapy, 2008
- Vancomycin Concentrations in Autosomal Dominant Polycystic Kidney DiseaseClinical Infectious Diseases, 2005
- Cyst Fluid Antibiotic Concentrations in Autosomal-Dominant Polycystic Kidney DiseaseAmerican Journal of Kidney Diseases, 1985